Literature DB >> 23453531

The "E" word: epilepsy and perceptions of unfair treatment from the 2010 Australian Epilepsy Longitudinal Survey.

M Bellon1, C Walker, C Peterson, P Cookson.   

Abstract

AIM: The aim of the current study was to examine self-report data on perceptions of unfair treatment due to epilepsy.
METHOD: We analyzed data from the 2010 Australian Epilepsy Longitudinal Survey, distributed to 621 registrants on the Australian Epilepsy Research Register. A total of 343 responses were received (55% response rate), providing insight into experiences of life with epilepsy in Australia. Responses relating to perceptions of unfair treatment in areas of employment, education and community participation as a result of epilepsy are reported in this article.
RESULTS: Forty-eight percent of respondents reported perceptions of unfair treatment as a result of their epilepsy, with most providing details of their experiences. Discrimination in the workplace remains of key concern, with 47% citing examples of unfair treatment in this setting.
CONCLUSIONS: In spite of Australian anti-discrimination laws, findings indicate that full-time employment rates for people with epilepsy are lower than previously reported, with further mechanisms for support required to improve education and reduce experiences of stigma.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23453531     DOI: 10.1016/j.yebeh.2013.01.016

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  2 in total

Review 1.  Stigma in epilepsy.

Authors:  Kirsten M Fiest; Gretchen L Birbeck; Ann Jacoby; Nathalie Jette
Journal:  Curr Neurol Neurosci Rep       Date:  2014-05       Impact factor: 5.081

2.  Experiences, expectations, and fears of adolescents with epilepsy or bronchial asthma.

Authors:  Susanne Marie Fisch; Martina Patrizia Neininger; Freerk Prenzel; Matthias Karl Bernhard; Frauke Hornemann; Andreas Merkenschlager; Wieland Kiess; Thilo Bertsche; Astrid Bertsche
Journal:  Eur J Pediatr       Date:  2018-07-03       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.